# Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer

> **NCT00291577** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 22 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Sunitinib (Sutent)
- **DRUG:** Taxotere

## Key facts

- **NCT ID:** NCT00291577
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-10
- **Final completion:** 2009-02
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2009-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291577, "Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00291577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*